巨噬细胞极化
SMAD公司
癌症研究
肺纤维化
巨噬细胞
免疫系统
纤维化
免疫学
医学
特发性肺纤维化
肺
肺泡巨噬细胞
内科学
炎症
信号转导
细胞生物学
生物
病理
体外
生物化学
作者
Zhaojuan Guo,Huaqiang Zhai,Ningning Wang,Ying Dai,Siyu Li,Guo-Xiu Liu,Ningning Li
出处
期刊:PubMed
日期:2018-11-01
卷期号:43 (22): 4370-4379
被引量:5
标识
DOI:10.19540/j.cnki.cjcmm.2018.0117
摘要
Macrophages are a group of immune cells with pluripotency and plasticity that can differentiate into different phenotypes under different microenvironments in vitro and in vivo. In the development of pulmonary fibrosis, there are alveolar macrophages and interstitial macrophages, which are polarized to different cell phenotypes at different stages of development. And their polarized phenotypes include M1 macrophages and M2 macrophages. In the inflammation early stages of pulmonary fibrosis, the increase of classical activated macrophages are helpful to clear pathogenic microorganisms and promote the progress of inflammation. In the fibrosis stage, the alternatively activated macrophages increased, which inhibiting the inflammatory reaction or directly promoting tissue fibrosis, on the other hand, it also promoting the fibrosis degradation. To clarify the polarization and polarization mechanisms of macrophages in pulmonary fibrosis will be conducive to the treatment of pulmonary fibrosis. In IPF, the polarization mechanism of M1 and M2 is closely related to TGF-β1/Smad. TGF-β1/Smad pathway plays an important regulatory role in liver fibrosis, renal fibrosis, myocardial fibrosis, scars, tumors and other diseases. Blocking the signaling of TGF-β1 by Smad3 and Smad4 is beneficial to inhibit the polarization of AM, which in turn helps to inhibit the progression of IPF.
科研通智能强力驱动
Strongly Powered by AbleSci AI